| |
| |
|
| Insider
Information: |
Root Jonathan D |
| Relationship: |
10% Owner |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
652,550 |
|
|
Indirect Shares
|
141,997 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$304,399 |
|
|
| Total
Shares |
794,547 |
|
|
| Total
Value |
$304,399 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -125.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Occam Networks Inc |
OCNW |
10% Owner |
2007-02-23 |
538 |
2007-02-23 |
0 |
Premium* |
|
|
Maxlinear Inc |
MXL |
10% Owner |
2011-02-15 |
0 |
2011-02-15 |
2,220 |
Premium* |
|
|
Atricure, Inc. |
ATRC |
10% Owner |
2012-06-06 |
0 |
2012-06-13 |
11,873 |
Premium* |
|
|
Inari Medical, Inc. |
NARI |
Director |
2024-04-24 |
541,149 |
2024-04-24 |
335 |
Premium* |
|
|
Silverback Therapeutics, Inc. |
SBTX |
Director |
2021-12-13 |
95,238 |
2021-12-13 |
0 |
Premium* |
|
|
Edgewise Therapeutics, Inc. |
EWTX |
Director |
2022-02-25 |
15,625 |
2022-02-25 |
0 |
Premium* |
|
|
Effector Therapeutics Ord Shs |
EFTR |
10% Owner |
2021-08-25 |
0 |
2022-08-03 |
127,569 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRC |
Atricure, Inc. |
10% Owner |
– – • |
2012-06-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(352,579) |
14,452 |
0 |
- |
|
| ATRC |
Atricure, Inc. |
10% Owner |
– – • |
2012-06-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(352,579) |
11,873 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
– • • |
2020-05-27 |
4 |
A |
$0.00 |
$0 |
I/I |
7,724,816 |
239,467 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
– • • |
2020-11-17 |
4 |
A |
$0.00 |
$0 |
I/I |
587,851 |
587,851 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
– • • |
2020-11-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,905,296) |
0 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
– • • |
2020-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
81,996 |
81,996 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
– • • |
2020-11-17 |
4/A |
A |
$0.00 |
$0 |
D/D |
81,996 |
333,791 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2020-12-08 |
4 |
A |
$0.00 |
$0 |
I/I |
2,174,179 |
105,012 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
– • • |
2021-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
685,827 |
685,827 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
– • • |
2021-03-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,389,513) |
0 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
– • • |
2021-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
94,101 |
427,892 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Director |
– • – |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
I/I |
3,473,543 |
3,473,543 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
– • – |
2021-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
93,972 |
521,864 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
– • – |
2021-05-13 |
4 |
A |
$0.00 |
$0 |
I/I |
685,826 |
685,826 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
– • – |
2021-05-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,389,511) |
0 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
|
– • • |
2021-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,380 |
526,226 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
|
– • • |
2021-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,982 |
524,846 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
Director |
– • • |
2021-08-25 |
4 |
A |
$0.00 |
$7,127,850 |
I/I |
4,822,114 |
149,486 |
0 |
- |
|
| SBTX |
Silverback Therapeutics, ... |
Director |
– • – |
2021-12-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,174,179) |
0 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Director |
– • – |
2022-02-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,473,543) |
0 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
• • – |
2022-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,420 |
528,646 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
• • – |
2022-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,983 |
531,629 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
• • – |
2023-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,412 |
534,041 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
• • – |
2023-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,982 |
537,023 |
0 |
- |
|
| EFTR |
Effector Therapeutics Ord... |
10% Owner |
– – • |
2022-08-01 |
4 |
S |
$0.79 |
$20,989 |
I/I |
(26,703) |
130,218 |
0 |
- |
|
74 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
